Carna Biosciences Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 11.4%.

Top 22 shareholders own 29.71% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
7.33%	Athos Capital Limited	1,400,000	JP¥434.0m	0%	0.68%
2.69%	Rakuten Investment Management, Inc.	514,100	JP¥159.4m	0%	0.07%
2.64%	Ono Pharmaceutical Co., Ltd.	504,500	JP¥156.4m	0%	no data
2.6%	Nomura Holdings Inc, Securities & Investment Arm	495,753	JP¥153.7m	-1.16%	no data
1.95%	SBI Holdings Inc., Asset Management Arm	372,466	JP¥115.5m	0%	0.04%
1.93%	Toshihiko Uehara	367,800	JP¥114.0m	0%	no data
1.75%	Kohichiro Yoshino	333,900	JP¥103.5m	0%	no data
1.59%	Kazuo Hotta	303,300	JP¥94.0m	0%	no data
1.48%	PineBridge Investments LLC	281,900	JP¥87.4m	0%	no data
1.42%	BNP Paribas Securities Corp, Asset Management Arm	270,300	JP¥83.8m	0%	0.01%
1.26%	Takahiro Suzuki	240,000	JP¥74.4m	0%	no data
0.59%	Morgan Stanley, Investment Banking and Brokerage Investments	112,400	JP¥34.8m	-88.8%	no data
0.56%	Masaaki Sawa	106,000	JP¥32.9m	0%	no data
0.53%	Norio Aikawa	102,000	JP¥31.6m	0%	no data
0.5%	Merrill Lynch & Co. Inc., Banking Investments	96,340	JP¥29.9m	-229%	no data
0.45%	Simplex Asset Management Co., Ltd.	86,300	JP¥26.8m	0%	0.02%
0.29%	Emi Yamamoto	54,600	JP¥16.9m	0%	no data
0.086%	Akinori Arimura	16,500	JP¥5.1m	0%	no data
0.042%	Atsuo Arita	8,000	JP¥2.5m	0%	no data
0.026%	Tsuguo Ogasawara	5,000	JP¥1.5m	0%	no data
0.0084%	LGT Capital Partners Ltd.	1,600	JP¥496.1k	0%	no data
0.0058%	Teruo Takayanagi	1,100	JP¥341.0k	0%	no data